CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Golay, J.
Right arrow Articles by Introna, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Golay, J.
Right arrow Articles by Introna, M.

Cell Growth & Differentiation, Vol 8, Issue 12 1305-1316, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Redundant functions of B-Myb and c-Myb in differentiating myeloid cells

J Golay, V Broccoli, GM Borleri, E Erba, M Faretta, L Basilico, GG Ying, G Piccinini, LH Shapiro, J Lovric, M Nawrath, K Molling, A Rambaldi and M Introna
Department of Immunology and Cell Biology, Istituto Ricerche Farmacologicalhe, Mario Negri, Milano, Italy.

We show in this report that the human myeloid leukemia cell line GFD8 is a useful model to compare the biological function of the structurally related c-Myb and B-Myb proto-oncogenes and to investigate the c-myb domains required for this function. GFD8 cells are dependent for growth on granulocyte-macrophage colony-stimulating factor and differentiate in response to phorbol myristate acetate (PMA). We have stably transfected this cell line with constructs constitutively expressing c-Myb or B-Myb. Deregulated expression of both c-Myb and B-Myb inhibited the differentiation observed in response to PMA and, in particular, the induction of the CD11b and CD11c antigens on the cell surface, and the induction of adherence. Furthermore, c-Myb and B-Myb enhanced expression of CD13 upon PMA treatment. Although deregulated Myb expression did not alter the growth factor dependence of the cells, it led to an increase in G2 relative to G1 arrest in cells induced to differentiate in response to PMA, whereas control vector-transfected cells were blocked mostly in G1. This decrease in G1 block took place despite normal induction of the cyclin-dependent kinase inhibitor protein p21 (CIP1/WAF1). Thus, GFD8 cells stably expressing the human B-Myb protein behaved in a manner indistinguishable from those stably expressing C-Myb for both differentiation and cell cycle parameters. In agreement with these findings and differently from most previous reports, transactivation assays show that B-myb can indeed act as a strong activator of transcription. Finally, we demonstrated that although the DNA-binding domain of c-myb is required for both the differentiation block and the shift in cell cycle after PMA treatment, phosphorylation by casein kinase II and mitogen-activated protein kinase at positions 11 and 12 or 532 of c-myb, respectively, are not. We conclude that c-Myb and B-Myb may activate a common cellular program in the GFD8 cell line involved in both differentiation and cell cycle control.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. J. Baker, A. Ma'ayan, Y. K. Lieu, P. John, M. V. R. Reddy, E. Y. Chen, Q. Duan, H.-W. Snoeck, and E. P. Reddy
B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development
PNAS, February 25, 2014; 111(8): 3122 - 3127.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. Vadasz, J. Marquez, M. Tulloch, N. A. Shylo, and M. I. Garcia-Castro
Pax7 is regulated by cMyb during early neural crest development through a novel enhancer
Development, September 1, 2013; 140(17): 3691 - 3702.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Papetti and L. H. Augenlicht
Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365
Am J Physiol Gastrointest Liver Physiol, September 1, 2011; 301(3): G508 - G518.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Zauli, R. Voltan, M. G. di Iasio, R. Bosco, E. Melloni, M. E. Sana, and P. Secchiero
miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells
Clin. Cancer Res., May 1, 2011; 17(9): 2712 - 2724.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Joaquin and R. J. Watson
The Cell Cycle-regulated B-Myb Transcription Factor Overcomes Cyclin-dependent Kinase Inhibitory Activity of p57KIP2 by Interacting with Its Cyclin-binding Domain
J. Biol. Chem., November 7, 2003; 278(45): 44255 - 44264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Powzaniuk, R. Trotta, M. J. Loza, A. Harth, R. V. Iozzo, L. C. Eisenlohr, B. Perussia, and B. Calabretta
B-Myb Overexpression Results in Activation and Increased Fas/Fas Ligand-Mediated Cytotoxicity of T and NK Cells
J. Immunol., July 1, 2001; 167(1): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. G. Lutz, A. Houzel-Charavel, C. Moog-Lutz, and Y. E. Cayre
Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid
Blood, April 15, 2001; 97(8): 2449 - 2456.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G.-G. Ying, P. Proost, J. van Damme, M. Bruschi, M. Introna, and J. Golay
Nucleolin, a Novel Partner for the Myb Transcription Factor Family That Regulates Their Activity
J. Biol. Chem., February 11, 2000; 275(6): 4152 - 4158.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Grassilli, P. Salomoni, D. Perrotti, C. Franceschi, and B. Calabretta
Resistance to Apoptosis in CTLL-2 Cells Overexpressing B-Myb Is Associated with B-Myb-dependent bcl-2 Induction
Cancer Res., May 1, 1999; 59(10): 2451 - 2456.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.